Stock Events

Stock Events

Avalo Therapeutics (C6K0.F) Q3 2026 Earnings

30JulConfirmed

Q3 2025

Q4 2025

Q2 2026

Next

-1.9

-1.44

-0.99

-0.54

Details

Expected EPS

-0.5392608

Actual EPS

N/A

Surprise EPS

0.54

Surprise Percent

+100%

Description

Avalo Therapeutics (C6K0.F) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.